Related Experiment Videos
Defining indications for artificial organ support in respiratory failure
Transactions - American Society for Artificial Internal Organs
|January 1, 1979
Summary
High-risk acute respiratory failure patients may benefit from early identification and temporary extracorporeal membrane oxygenation (ECMO) support. This intervention is suitable if irreversible organ damage is absent, improving patient outcomes.
Area of Science:
- Critical Care Medicine
- Respiratory Physiology
- Medical Technology
Background:
- Acute respiratory failure (ARF) carries a high mortality risk.
- Early identification of high-risk patients is crucial for timely intervention.
- Extracorporeal membrane oxygenation (ECMO) offers a potential life-saving therapy.
Purpose of the Study:
- To outline methods for analyzing high-risk ARF patients.
- To identify criteria for early intervention in ARF.
- To define the role of temporary ECMO in managing severe ARF.
Main Methods:
- Analysis of patient data to identify high-risk indicators in ARF.
- Clinical assessment for early signs of respiratory deterioration.
- Evaluation of ECMO candidacy based on reversibility of organ damage.
Main Results:
- Specific methods can identify a subset of high-risk ARF patients early.
- Temporary ECMO support is a viable option for selected high-risk ARF patients.
- Absence of irreversible damage is a key determinant for ECMO indication.
Conclusions:
- Early identification and intervention strategies are vital for high-risk ARF patients.
- Temporary ECMO can be a critical treatment for select ARF patients.
- Careful patient selection, excluding irreversible damage, optimizes ECMO therapy outcomes.